Copertina

Pharmacogenetics of antidepressants

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Alessandro Serretti
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz 2007
Soggetti:	Medicina
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The concept of melancholia and antidepressant treatment
di: Per Kragh Sørensen
Pubblicazione: (2004)

Trends in depression diagnosis and consumption of antidepressants in Lithuania in 2004–2009
di: Liubov Kavaliauskienė
Pubblicazione: (2011)

Pharmacogenetic analysis of the absorption kinetics of cyclosporine in a population of Spanish cardiac transplant patients
di: B. Isla Tejera
Pubblicazione: (2009)

Tryptophan and serotonin in blood and platelets of depressed patients. Effect of an antidepressant treatment
di: Carmen Lara
Pubblicazione: (2006)

Pharmacogenetic basis of glaucoma
di: Elena Milla
Pubblicazione: (2024)

Information on antidepressants for psychiatric inpatients: the divide between patient needs and professional practice
di: Franciska A. DESPLENTER
Pubblicazione: (2013)

Does the antidepressant-like effect of mirtazapine and venlafaxine differ between male and female rats?
di: Adriana Álvarez Silva
Pubblicazione: (2020)

Nicotine antidepressant effects as a predictor of response to desimipramine or fluoxetine in non-smoking major depressed patients
di: Rafael J. Salín Pascual
Pubblicazione: (2002)

French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in Pharmacogenetics
di: Nicolas Picard, et al.
Pubblicazione: (2026)

The use of antidepressants in medicine
di: Lisieux Elaine de Borba Telles
Pubblicazione: (2013)

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects
di: Emma C. Bernsen, et al.
Pubblicazione: (2025)

Are antidepressants effective in treating depression?
di: Tripdatabase
Pubblicazione: (2025)

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
di: John Henry McDermott, et al.
Pubblicazione: (2025)

Enhancing Asthma Pharmacogenetics Through Subtype‐Specific Associations
di: Shraddha Piparia, et al.
Pubblicazione: (2024)

Animal Models and Treatment of Pulmonary Fibrosis: Pharmacogenetic and Nonpharmacogenetic
di: Xingyu Fang, et al.
Pubblicazione: (2026)

Age an important variable in response to antidepressants
Pubblicazione: (2025)

Pharmacogenetic Approaches to Optimize Bioequivalence Studies in Generic Drug Development
di: Jihyun Bae, et al.
Pubblicazione: (2025)

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study
di: Henk‐Jan Guchelaar, et al.
Pubblicazione: (2025)

Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum
di: Oluwasegun Eniayewu, et al.
Pubblicazione: (2024)

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations
di: Luis Jaramillo‐Valverde, et al.
Pubblicazione: (2024)

Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy
di: Rita Nogueiras‐Álvarez, et al.
Pubblicazione: (2024)

Early antidepressant exposure rewrites the script of coping.
di: Ferreira, Carla S S, et al.
Pubblicazione: (2026)

Are antidepressants effective in treating depression in individuals with autism?
di: Tripdatabase
Pubblicazione: (2026)

Switching concerns: Bipolar disorder and the antidepressant dilemma
di: René Ernst Nielsen
Pubblicazione: (2024)

Study finds helpful treatment for antidepressant nonresponders
di: Valerie A. Canady
Pubblicazione: (2024)

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
di: Amorim, Gustavo, et al.
Pubblicazione: (2025)

Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data
di: Bianca Kruger, et al.
Pubblicazione: (2024)

Pharmacogenetics of Mycophenolic Acid in Patients of African Descent: Underrepresentation of African Data
di: Migael Mouton, et al.
Pubblicazione: (2026)

Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights
di: Siwaporn Manomaisantiphap, et al.
Pubblicazione: (2025)

French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten
di: Louis Lebreton, et al.
Pubblicazione: (2024)

Self‐Reported Pharmacogenetic Medication Use in the Our Future Health Cohort
di: Padraig Dixon, et al.
Pubblicazione: (2026)

Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature
di: Cinzia Dello Russo, et al.
Pubblicazione: (2026)

Pharmacogenetic Study of Anti‐TB Drugs in the Native Ancestry Peruvian Population
di: Luis Jaramillo‐Valverde, et al.
Pubblicazione: (2025)

Alcohol use history predicts antidepressant response to ketamine
Pubblicazione: (2026)

Review confirms antidepressant efficacy in post‐MI depression
Pubblicazione: (2025)

Impact of antidepressants' serotonin transporter affinity on bleeding events
di: Y. W. Francis Lam
Pubblicazione: (2026)

Stopping antidepressant in pregnancy not linked to adverse postpartum outcomes
Pubblicazione: (2024)

Increase in antidepressants among females seen after COVID
di: Valerie A. Canady
Pubblicazione: (2024)

The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical Guidelines
di: Janine Scholefield, et al.
Pubblicazione: (2026)

Pharmacogenetic Considerations in Caffeine Toxicity: Insights Prompted by the “Death Coffee” Case Series
di: Yuji Kamikubo
Pubblicazione: (2025)